Adrenal Disorders

Resource Center

FDA Alerts

Endocrinology

FDA Approves New Drug for Cushing Disease

03/09/2020

The new treatment is the first FDA-approved drug to address the overproduction of cortisol in Cushing disease by blocking the enzyme known as 11-beta-hydroxylase and preventing cortisol synthesis.

03/09/2020

Research Summaries

Primary Aldosteronism

Aldosteronism Testing Is Rare, Despite Guidelines

01/04/2021

Despite guideline recommendations, evidence suggests there is inadequate testing for primary aldosteronism among patients with treatment-resistant hypertension. In a recent study, researchers examined the...

01/04/2021

Endocrinology

FDA Approves New Drug for Cushing Disease

03/09/2020

The new treatment is the first FDA-approved drug to address the overproduction of cortisol in Cushing disease by blocking the enzyme known as 11-beta-hydroxylase and preventing cortisol synthesis.

03/09/2020

Primary Aldosteronism

AF in Primary Aldosteronism: What Treatment Strategies Could Lower Incidence?

03/03/2020

Researchers aimed to determine whether target treatment to prevent new-onset atrial fibrillation was effective among patients with primary aldosteronism compared with controls with essential hypertension. ...

03/03/2020

Hormones

"Nonfunctional" adrenal tumors tied to increased diabetes risk

08/04/2016

By Marilynn Larkin NEW YORK (Reuters Health) - Benign, so-called "nonfunctional" adrenal tumors may increase the risk of type 2 diabetes, researchers report.

08/04/2016

Endocrinology

Nuclear medicine helps localize tumor in ectopic Cushing's syndrome

07/23/2015

<p>Nuclear medicine imaging significantly improves the ability to localize the tumor in ectopic Cushing's syndrome, according to a new systematic review.</p>

07/23/2015

September 2024

Current Issue

September 2024

Volume 64

Issue 9